Showing results (141-150 of 1,297) with videos related to
Sort By:
Pageof 130
Diabetes Research and Clinical Practice|April 1, 2018
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic reviewKarin Rådholm, Jason Hy Wu, Muh Geot Wong, et al.International Journal of Cardiology|October 16, 2023
Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trialSneha S Jain, Jie Yu, Clare Arnott, et al.Nephrology (Carlton, Vic.)|May 12, 2012
Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular riskNigel D Toussaint, Eugenie Pedagogos, Sven-Jean Tan, et al.BMJ (Clinical Research Ed.)|February 27, 2008
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsGiovanni F M Strippoli, Sankar D Navaneethan, David W Johnson, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 22, 2016
Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial FibrillationMin Jun, Matthew T James, Zhihai Ma, et al.Nephrology (Carlton, Vic.)|December 5, 2015
Comorbidity recording and predictive power of comorbidities in the Australia and New Zealand dialysis and transplant registry compared with administrative data: 2000-2010Sradha Kotwal, Angela C Webster, Alan Cass, et al.Diabetes, Obesity & Metabolism|July 22, 2020
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS ProgramDavid R Matthews, Carol Wysham, Melanie Davies, et al.Diabetes, Obesity & Metabolism|November 16, 2019
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS ProgramToshiaki Ohkuma, Luc Van Gaal, Wayne Shaw, et al.Journal of the American Geriatrics Society|March 19, 2025
The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE TrialsTu N Nguyen, Jie Yu, Vlado Perkovic, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 10, 2019
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trialVlado Perkovic, Audrey Koitka-Weber, Mark E Cooper, et al.Pageof 130